|1.||Nishiyama, Akira: 4 articles (01/2013 - 09/2008)|
|2.||Kobori, Hiroyuki: 4 articles (01/2013 - 09/2008)|
|3.||Saavedra, Juan M: 3 articles (11/2015 - 04/2014)|
|4.||Saku, Keijiro: 3 articles (03/2013 - 03/2006)|
|5.||Miura, Shin-ichiro: 3 articles (03/2013 - 03/2006)|
|6.||Watanabe, Kenichi: 3 articles (11/2010 - 01/2003)|
|7.||Aizawa, Yoshifusa: 3 articles (11/2010 - 01/2003)|
|8.||Kodama, Makoto: 3 articles (11/2010 - 01/2003)|
|9.||Miyata, Toshio: 3 articles (09/2009 - 05/2003)|
|10.||Mori, Takefumi: 3 articles (01/2009 - 04/2006)|
01/01/2012 - "In this review, the beneficial effects of sartans in the management of stroke are discussed, considering the results of experimental and clinical studies."
04/01/2001 - "The aim of this study was to evaluate the effect of different angiotensin II type 1 receptor antagonists in stroke-prone spontaneously hypertensive rats (SHRSP). "
01/01/2012 - "In humans, sartans are safe in hypertensive acute stroke patients and may offer advantages independent of blood pressure control. "
01/01/2012 - "The anti-inflammatory effects of sartans play a role in reducing cerebral injury following stroke, and improve the outcome of stroke in terms of improving cognitive function. "
01/01/2012 - "Significant beneficial effect of AT-1 receptor blockers (sartans) in stroke."
|2.||Hypertension (High Blood Pressure)
08/01/2015 - "Ang II-AT1 receptors play an important role in mediating virtually all of the physiological actions of Ang II. Several drugs (SARTANs) are available, which can block the AT1 receptor effectively and lower the blood pressure in the patients with hypertension. "
08/01/2014 - "Angiotensin II type 1 receptor blockers (ARBs) are widely used in treating hypertension. "
03/01/2013 - "How important is it to control nocturnal hypertension with angiotensin II type 1 receptor blockers?"
01/01/2013 - "Treatment with angiotensin II type 1 receptor blockers (ARB) is a proven successful intervention for hypertension with type 2 diabetes. "
04/01/2012 - "Angiotensin II type 1 receptor blockers (ARBs) dominate the management of hypertension, but evidence of their role in angiogenesis is contradictory. "
11/01/2007 - "Angiotensin II type 1 receptor blockers (ARBs) are used for controlling blood pressure and treating heart failure in a broad range of patients, including those with diabetes and the elderly. "
05/01/2002 - "Promising data have been provided for angiotensin II Type 1 receptor antagonists in experimental models of heart failure. "
05/01/2002 - "Angiotensin II Type 1 receptor antagonists in chronic heart failure."
10/09/2001 - "Angiotensin II type 1 receptor blockers and congestive heart failure."
06/01/2011 - "Angiotensin II type 1 receptor antagonists (AT1R blockers, or ARBs) are used commonly in the treatment of cardiovascular disorders such as heart failure and hypertension. "
08/01/2013 - "Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists."
12/01/2009 - "It was reported that inhibition of RAS with angiotensin II type 1 receptor blockers (ARBs) or angiotensin converting enzyme inhibitors (ACEIs) is effective in prevention of atherosclerosis. "
03/01/2007 - "Angiotensin II type 1 receptor antagonists (AIIA) are beneficial for the prevention of atherosclerosis and diabetic nephropathy suggesting that angiotensin II (Ang II) promotes the development of these diseases. "
01/01/2015 - "Our data support the hypothesis that even in advanced atherosclerosis anti-inflammatory treatment, using angiotensin II type 1 receptor blockers and calcium channel antagonists of the dihydropyridine type can attenuate atherosclerotic lesion progression."
01/01/2009 - "Statins, angiotensin II type 1 receptor blockers, angiotensin-converting enzyme (ACE) inhibitors, the aldosterone antagonist eplerenone and the renin inhibitor aliskiren enhance NO bioactivity and reduce atherosclerosis progression through multiple mechanisms."
|5.||Brain Injuries (Brain Injury)
11/01/2015 - "This study strongly suggests that sartans with dual AT1R blocking and PPARγ activating properties have therapeutic potential for traumatic brain injury. "
11/01/2010 - "Indeed, studies in the last 5 years have shown that both angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor antagonists (AT(1)RAs) can prevent/ameliorate radiation-induced brain injury, including cognitive impairment, in the rat. "
11/01/2015 - "To test whether these drugs may be effective in treating traumatic brain injury, we selected two sartans, candesartan and telmisartan, of proven therapeutic efficacy in animal models of brain inflammation, neurodegenerative disorders and stroke. "
|1.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|2.||Angiotensin Receptor Antagonists
|4.||Calcium Channel Blockers (Blockers, Calcium Channel)
|6.||Antihypertensive Agents (Antihypertensives)
|8.||Calcium Channels (Calcium Channel)
|2.||Drug Therapy (Chemotherapy)
|3.||Home Nursing (Nursing, Home)